We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Enhance Complex mAb and AAV Gene Therapy Production

Thermo Fisher infographic detailing components of peptones for enhancing monoclonal antibody and gene therapy production
Credit: Thermo Fisher Scientific

The biopharmaceutical industry faces mounting pressure to produce complex monoclonal antibodies (mAbs) and adeno-associated virus (AAV) gene therapies more efficiently while maintaining stringent quality standards.


Download this infographic to discover how incorporating peptones into your workflow can revolutionize your biopharmaceutical manufacturing processes.


Discover:

  • Improved cell growth and viability, leading to more efficient and productive biopharmaceutical manufacturing processes.
  • Reduced variability in production, ensuring higher quality and reproducibility.
  • Cost-effective production, reducing the need for additional manufacturing capacity, thus lowering overall production expenses.


Brought to you by

Download the Infographic for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.